Microarray Market to Grow at a CAGR of 8.7% During 2025-2035.
Microarray market is driven by the increasing demand for advanced genomic and proteomic research tools, rising prevalence of chronic and genetic disorders, and growing adoption of personalized medicine globally. The expanding use of DNA, protein, peptide, and tissue microarrays in disease diagnosis, prognosis, drug discovery, and pharmacogenomics applications is significantly supporting market growth. In addition, technological advancements in molecular diagnostics, increasing investments in biotechnology and life sciences research, and the growing focus on precision healthcare are accelerating the adoption of microarray technologies across healthcare and pharmaceutical industries.
Browse the full report description of “Microarray Market Size, Share & Trends Analysis by Type (DNA Microarrays, Protein Microarray, Peptide Microarray, Tissue Microarray, and Others), By Application (Diagnosis & Prognosis, Pharmacogenomics & Theragnostic, Drug Discovery, and Others), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/microarray-market
High-throughput microarray platforms segment is expected to account for a major market share in 2025
High-throughput microarray platforms are expected to hold a major market share in 2025, primarily due to the increasing demand for large-scale genomic analysis, population genomics studies, and precision medicine research programs. These platforms enable rapid and scalable genetic analysis, supporting applications such as biobanking, disease screening, pharmacogenomics, and clinical research. The introduction of the Infinium XT Microarray Suite by Illumina during 2024–2025 reflects the growing industry focus on scalable and high-throughput genomic technologies designed for large-scale genetic screening and population health initiatives. Rising investments in genomics research and increasing adoption of precision medicine approaches are expected to significantly contribute to the growth of the high-throughput microarray platforms segment.
Automated microarray systems segment is expected to account for a major market share in 2025
Automated microarray systems are expected to hold a major market share in 2025 owing to the increasing need for faster diagnostic workflows, reduced manual intervention, and high-efficiency genomic testing solutions across clinical and research laboratories. These systems improve laboratory productivity by streamlining sample processing, assay execution, and data generation while supporting high testing volumes with enhanced accuracy and reproducibility. The launch of a new automated microarray platform and assays by Thermo Fisher Scientific in October 2025 highlights the growing industry emphasis on accelerating genomic testing and improving turnaround times for molecular analysis applications. Increasing adoption of automation technologies in diagnostics and expanding genomic research activities are expected to further support the growth of the automated microarray systems segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404